GLP-1 agonists reduce appetite and slow gastric emptying, which can lead to lower blood sugar levels, especially when combined with other glucose-lowering agents
Those misuse rates were comparable to those for phentermine-topiramate (Topamax), a combination weight-loss stimulant drug
The Prevalence, Odds and Predictors of Lifespan Comorbid Eating Disorder Among People With a Primary Diagnosis of Bipolar Disorders, and Vice-Versa: Systematic Review and Meta-Analysis
You can certainly make the case that the comparison group - insulin treatment - may put patients at higher cardiovascular risk because of the negative impact of elevated insulin levels
Beyond-use dating Compounded medications have beyond-use dates (BUDs) rather than expiration dates
To find an RDN, use the Find a Nutrition Expert tool at www.eatright.org Reviewed by: Anoosh Mahum, UGA Dietetic Intern References Aziz, M.A, et al